COVID-19 Get an extensive COVID-19 analysis on the Disposable Syringe Market Request Free Sample

Market Summary

The Disposable Syringe market was valued at USD 7.10 billion in 2018 and is predicted to grow at a CAGR of 5.6%, with forecasts for 2026 eclipsing USD 11.00 billion. The market is driven by the growing prevalence of chronic diseases, especially diabetes, an increase in the usage of Botox, increased adoption of injectable drugs, technological advancements in syringes, an increase in the geriatric population, a growing number of vaccination and immunization programs. According to WHO, 16 billion injections are administered each year globally. A disposable syringe is a medical tool used to administer injections of intravenous drugs into the patient’s blood stream or to draw blood sample.

Click here to enlarge

The disposable syringe allows doctors to use the syringe once then discard it. The syringes are meant for one-time usage. A disposable syringe consists of a plastic barrel with a needle of varying size attached to it. A syringe is a cylindrical tube which has a piston or plunger which fits in tightly to form a reciprocating pump. The plunger is linearly pulled and pushed along the inside of the tube to take in and expels liquid or gas, respectively, through a discharge orifice present in front of the tube. Syringes are used in medicine to administer injections, infuse fluids, or gas into the bloodstream and draw/measure liquids. Disposable syringes are preferred over glass syringes since they are more safe and sterile. Moreover, it is also user friendly and cost-efficient.

The rise in the population of geriatric patient, rising rate of diabetes across the world is another healthcare crises that drives the market growth. In addition, the convenience and practical approach in equipment handling is anticipated to boost the market during the forecast period. However, since disposable syringes are generally made of plastic and need to be disposed of after a single use, it raises environmental concerns. If not properly disposed of, these syringes can cause a health hazard due to the pathogens present in them. These factors may cause a shift to glass syringes and hamper the disposable syringe market.

The global disposable syringe market has been segmented on the basis of type, application, and end-use. The research takes a closer look at prominent driving factors responsible for the exorbitant 5.6% CAGR. The study also analyses the market share of each region, company, and product. The report also presents constraints, opportunities, threats, challenges, and Investment opportunities prevailing in the market.



Key Coverage

Region/country wide statistics with respect to year, regional prevalence

Estimation of market size

Types of Products, upcoming analyzed

Alternatives analyzed

Types of use analyzed

Status of ongoing developments

Analysis of regulatory framework/regulatory bodies

Demand and supply gap analysis

Competitor pricing strategy

Market share analysis

Strategic recommendations for new entrants/existing members/in key business segments

Market trends

Drivers, constraints, opportunities, threats, challenges, Investment opportunities

Competitive landscaping

Company profiling with strategies, financials and recent developments

Salient Features

The reason for such a wide market share of the disposable syringe market can be attributed to 60% of drugs being comprised of injectable biologics. For instance, USFDA approved Dupilumab for moderate to severe asthma Injectable medicines are believed to be significantly more effective than other methods of therapeutic intake.

Industry players increasingly investing in R&D of new chemicals that are more potent than existing drugs is likely to augment the growth over the forecast period.

Strongest driving force is the rising incidence of chronic illnesses that require medical injections. According to International Diabetes Federation, the diabetic patients are forecasted to grow from 415 million in 2015 to almost 642 million by 2040 across the globe, rapidly increasing the demand for disposable syringes.

For instance, Xeris’s severe low blood sugar pen gets FDA approval in September 2019 which is the first pre-mixed, ready-to-use prefilled syringe glucagon for severely low blood sugar (hypoglycemia).

Multiple product launches and partnerships have also propelled the market. For instance, Phillips and B.Braun launched onvision needle tip tracking which is an ultrasound guidance solution for real-time needle tip tracking in regional anesthesia.

Rising concern about needle stick injuries and accidental infections due to reusable syringes is shifting consumer and doctoral preference to disposable syringes. According to a WHO study, around 3 million patients were affected by a disease in 2003 due to contaminated syringes. 39% new hepatitis C cases, 37% of new hepatitis B cases, and about 5.5% new cases of HIV/AIDS were due to contaminated needles.

Companies Considered

Braun Medical, Inc.; Fresenius Kabi AG;Baxter International, Inc.; Flextronics International Vita Needle Company; Terumo Corporation; Novo Nordisk; UltiMed, Inc. ;Henke-Sass, Wolf; Covidien; Retractable Technologies, Inc.; and Becton, Dickinson and Company are dominating players in the market and are the companies considered for this report.

Market-o-Nomics

According to the WHO, therapeutics segment dominates the market holding of 90% market share. Delivery of insulin comprises a large share in therapeutic injections. High prevalence of diseases that require high consumption of injections such as HIV infection, malaria, tuberculosis, and dengue results in drives the market

Safety syringe accounted for the largest share in 2015 since they eliminate the risk of patient-to-patient transmission of infections. Safety syringes are further segmented into retractable and non-retractable, where non-retractable syringes had a bigger share among the two. According to NOVONOUS estimates, Indian safety syringes and needles market is forecasted to hold a CAGR of 19.0% till 2020 and hold its market share. Safety syringes are forecasted to hold a revenue market share of 83.3% by 2023

On the basis of end use, hospitals are predicted to hold the largest market share. Hospitals currently account for 66.5% of revenues in the global syringe market

Blood collection centers are estimated to contribute USD 1.8 billion in revenues by the end of the forecast period

Diabetic care centers are the fastest growing segment. By the end of 2022, USD 800 Million is estimated to be generated through the selling of syringes in diabetic care centers across the world

Significant investment was made by Max-Planck Institute in collaboration with the Federal Government of Germany in Europe. The European Molecular Biology Laboratory’s European Institute, backed by the UK Government, invested over USD 93 million for ELIXIR research infrastructure.

North America is the chief revenue generator holding 47.1% of the market revenue share due to high prevalence of target diseases and increasing preference for injectable drugs are the key factors influencing industry growth. By the end of 2016, North America disposable syringe makers was estimated to generate a revenue of USD 3.9 billion

Segments Covered

This report predicts revenue growth and CAGR at a global, regional & country level, and analyses the markets by studying the drivers, constraints, opportunities, threats, challenges, Investment opportunities, products, uses, trends, market shares in each of the sub-segments from 2019 to 2026. For the purpose of this study, Reports and Data have segmented the global Disposable Syringe market report based on product type, application, end use and region:

Product type Outlook (Revenue, USD Million; 2016-2026)

General Syringes

Specialized Syringes

Safety Syringes

Pre-filled Syringes

Others

Application Outlook (Revenue, USD Million; 2016-2026)

Immunization Injections

Therapeutic Injections

End Use Outlook (Revenue, USD Million; 2016-2026)

Hospitals

Blood collection centers

Diabetic centers

Veterinary Clinics

Others

Regional Outlook (Revenue, USD Million; 2016-2026)

North America U.S. Canada

Europe Germany France UK Spain Italy Rest of the Europe

Asia Pacific China India Japan Rest of Asia-Pacific

Middle East & Africa

Latin America Brazil

